Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.

Authors:
Araujo JL; Altorki NK; Sonett JR; Rodriguez A; Sungur-Stasik K and 3 more

Journal:
Therap Adv Gastroenterol

Publication Year: 2016

DOI:
10.1177/1756283X16657985

PMCID:
PMC5076766

PMID:
27803735

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Therap Adv Gastroenterol

Abbreviation: Therap Adv Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and…
Li M; Chen S; Li S and 13 more (2024) - Transparency Score: 3/6
Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in in…
Nigam GB; Chatten K; Sharara A and 6 more (2024) - Transparency Score: 4/6
Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary trac…
Ge P; Wu Y. (2024) - Transparency Score: 3/6
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with u…
Calafat M; Torres P; Tosca-Cuquerella J and 56 more (2024) - Transparency Score: 3/6
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should <i>K…
Béchade D; Palmieri LJ; Bonhomme B and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement: The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: This study was funded in part by a Career Development Award (K07 CA132892) and an Administrative Supplement (CA132892-02S1) from the National Cancer Institute (USA)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025